Alpha Cognition (NASDAQ:ACOG) COO Lauren D’angelo Buys 3,500 Shares

Alpha Cognition Inc. (NASDAQ:ACOG) COO Lauren D’angelo bought 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average price of $5.76 per share, with a total value of $20,160.00. Following the transaction, the chief operating officer directly owned 140,695 shares of the company’s stock, valued at $810,403.20. This represents a 2.55% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Alpha Cognition Trading Up 0.9%

NASDAQ ACOG opened at $5.80 on Wednesday. Alpha Cognition Inc. has a 12 month low of $4.50 and a 12 month high of $11.54. The stock has a market cap of $126.27 million, a PE ratio of -4.30 and a beta of 2.38. The stock’s 50 day moving average is $6.07 and its 200 day moving average is $5.91.

Alpha Cognition (NASDAQ:ACOG) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.37) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.04. Alpha Cognition had a negative net margin of 232.23% and a negative return on equity of 58.35%. The business had revenue of $3.53 million during the quarter, compared to analyst estimates of $3.42 million. On average, analysts forecast that Alpha Cognition Inc. will post -1.34 EPS for the current fiscal year.

Institutional Trading of Alpha Cognition

Hedge funds have recently made changes to their positions in the business. Aristides Capital LLC grew its position in Alpha Cognition by 1.4% in the first quarter. Aristides Capital LLC now owns 218,510 shares of the company’s stock worth $1,200,000 after acquiring an additional 3,052 shares in the last quarter. Ikarian Capital LLC increased its position in shares of Alpha Cognition by 11.6% during the 4th quarter. Ikarian Capital LLC now owns 1,056,259 shares of the company’s stock valued at $6,866,000 after purchasing an additional 110,000 shares during the last quarter. Sphera Funds Management LTD. raised its holdings in Alpha Cognition by 67.6% during the 4th quarter. Sphera Funds Management LTD. now owns 567,616 shares of the company’s stock valued at $3,690,000 after buying an additional 228,864 shares during the period. Opaleye Management Inc. lifted its position in Alpha Cognition by 1,698.5% in the fourth quarter. Opaleye Management Inc. now owns 2,070,784 shares of the company’s stock worth $13,460,000 after buying an additional 1,955,642 shares during the last quarter. Finally, ACT Capital Management LLC purchased a new position in Alpha Cognition during the fourth quarter worth $335,000.

Analysts Set New Price Targets

Several research analysts have commented on ACOG shares. HC Wainwright reissued a “buy” rating and set a $18.00 price objective on shares of Alpha Cognition in a report on Monday, April 27th. Craig Hallum started coverage on Alpha Cognition in a research report on Friday, April 17th. They issued a “buy” rating and a $14.00 target price on the stock. Finally, Wall Street Zen cut Alpha Cognition from a “hold” rating to a “sell” rating in a report on Saturday, May 2nd. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, Alpha Cognition has a consensus rating of “Buy” and a consensus price target of $16.00.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.